In this blog post by Dr Mikhail Blagosklonny, he summarizes the evidence in support of the use of mTORs (such as rapamycin) and benevolent glucose intolerance… Read more »
Mikhail V. Blagosklonny, M.D., PhD, Professor of Oncology at Roswell Park Cancer Institute, Buffalo, NY, USA, is an author of more than 250 scientific papers on cancer and aging, with h-index 93 (google scholar). Currently, he serves as Editor-in-Chief of Cell Cycle, Oncotarget and Aging.
Latest posts by Mikhail Blagosklonny (see all)
- Can fasting or pseudo-diabetes have a positive effect on aging and health? - 19th September 2019